EGFR and hepatocellular carcinoma: GP73 plays a role in the development of HCC through multiple mechanisms, by promoting the epithelial–mesenchymal transition in HCC cells, by interacting with EGFR to control the latter’s cell-surface recycling [54,55], or partly by targeting TGF-β1/Smad2 signalling [56].